Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;18(3):208-15.
doi: 10.4104/pcrj.2009.00053.

Improving the process and outcome of care in COPD: development of a standardised assessment tool

Affiliations

Improving the process and outcome of care in COPD: development of a standardised assessment tool

Paul Jones et al. Prim Care Respir J. 2009 Sep.

Abstract

Introduction: A major goal of COPD treatment is to reduce symptom burden and ensure that the patient's health is as good as possible. This goal requires regular systematic assessment of the patient's COPD with clear and efficient communication between the patient and clinician.

Aim: To explore patient and physician descriptions of COPD attributes, in order to inform content development of a patient-reported clinical assessment tool.

Methods: Qualitative research methods (one-to-one interviews and patient focus groups) were used to elicit key characteristics to evaluate COPD health status and explore how patients with COPD experience their condition. ATLAS.ti version 5.0 was used to identify major themes and generate an item pool.

Results: Fifty-eight patients with COPD (GOLD stages 1-4; MRC grades 2-5) and 10 clinicians participated in this research. Twenty-one items were generated, capturing patient assessment of breathlessness, wheeze, cough, sleep, activity limitation, energy/fatigue, social function, and anxiety.

Conclusions: This qualitative study identified a broad range of items that are potentially suitable for inclusion in a short, simple COPD assessment tool for use in routine clinical practice.

PubMed Disclaimer

Conflict of interest statement

PJ has received fees from pharmaceutical companies, including GlaxoSmithKline, for speaking at meetings and participating in advisory board meetings and has received support for research from GlaxoSmithKline.

Publication types